BUIOX
Price
$17.37
Change
+$0.12 (+0.70%)
Updated
Sep 26 closing price
Net Assets
69.52M
NRGSX
Price
$63.48
Change
+$0.48 (+0.76%)
Updated
Sep 26 closing price
Net Assets
8.83B
Interact to see
Advertisement

BUIOX vs NRGSX

Header iconBUIOX vs NRGSX Comparison
Open Charts BUIOX vs NRGSXBanner chart's image
Buffalo Early Stage Growth Instl
Price$17.37
Change+$0.12 (+0.70%)
VolumeN/A
Net Assets69.52M
Neuberger Berman Genesis R6
Price$63.48
Change+$0.48 (+0.76%)
VolumeN/A
Net Assets8.83B
BUIOX vs NRGSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BUIOX vs. NRGSX commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BUIOX is a Hold and NRGSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NRGSX has more cash in the bank: 8.83B vs. BUIOX (69.5M). NRGSX pays higher dividends than BUIOX: NRGSX (0.06) vs BUIOX (0.00). BUIOX was incepted earlier than NRGSX: BUIOX (6 years) vs NRGSX (13 years). BUIOX (1.35) is less costly to investors than NRGSX (0.74). BUIOX is a more actively managed with annual turnover of: 18.00 vs. NRGSX (13.00). NRGSX has a lower initial minimum investment than BUIOX: NRGSX (0) vs BUIOX (250000). BUIOX annual gain was more profitable for investors over the last year : 3.02 vs. NRGSX (-6.97). NRGSX return over 5 years is better than : 7.76 vs. BUIOX (-5.96).
BUIOXNRGSXBUIOX / NRGSX
Total Expense Ratio1.350.74182%
Annual Report Gross Expense Ratio1.350.74182%
Fund Existence6 years13 years-
Gain YTD3.950-2.862-138%
Front LoadN/AN/A-
Min. Initial Investment2500000-
Min. Initial Investment IRAN/AN/A-
Net Assets69.5M8.83B1%
Annual Yield % from dividends0.000.06-
Returns for 1 year3.02-6.97-43%
Returns for 3 years26.3312.34213%
Returns for 5 years-5.967.76-77%
Returns for 10 yearsN/A17.91-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APPEF0.54N/A
N/A
Appen Ltd.
CADLF5.52N/A
N/A
CADELER AS
PUMXF0.10N/A
N/A
Puma Exploration, Inc.
ICGUF27.50N/A
N/A
Intermediate Capital Group Plc.
AZNCF146.16-3.59
-2.40%
AstraZeneca Plc